Towards precision anti-tumor vascular targeting therapy by lentiviral vectors carrying VEGFR2-specific nanobody


Introduction: Cancer is one of the main causes of morbidity and mortality worldwide. Angiogenesis is general hallmark in the tumor growth and metastasis of cancers. Accordingly, therapies targeting angiogenesis and tumor... [ view full abstract ]


  1. Roshanak Ahani (Pasteur Institute of Iran)
  2. Hossein Etemadzadeh (Pasteur Institute of Iran)
  3. Nasir Mohajel (Pasteur Institute of Iran)
  4. Reza Ahangari Cohan (Pasteur Institute of Iran)
  5. Mahdi Behdani (Pasteur Institute of Iran)
  6. Farzin Roohvand (Pasteur Institute of Iran)
  7. Kayhan Azadmanesh (Pasteur Institute of Iran)

Topic Area

Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et


PS3 » Poster Session (13:30 - Wednesday, 27th June, Main hall)

Presentation Files

The presenter has not uploaded any presentation files.